Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda.


Journal

Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665

Informations de publication

Date de publication:
31 12 2023
Historique:
medline: 8 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

HIV risk reduction counselling may reduce risk-taking behaviours. Yet, concerns remain about risk compensation among individuals initiating pre-exposure prophylaxis (PrEP). We assessed changes in risky sexual behaviour indicators among HIV vaccine preparedness study participants who received regular risk reduction counselling and referral for PrEP in Masaka, Uganda. Adults (18-39 years) at high risk of HIV infection were enrolled in the study between July 2018 and December 2021. Data were collected on socio-demographic factors (baseline) and self-reported sexual risk behaviours (baseline, six monthly). HIV testing and risk-reduction counselling and referral for PrEP were done quarterly. Participants who had completed at least 1 year of follow-up were included in the analysis. Proportional differences and McNemar chi-square tests were used to assess changes in the prevalence of self-reported risky sexual behaviour indicators between baseline and 1 year. Logistic regression was used to assess the predictors of unchanged/increased HIV risk at 1 year. Three hundred participants [132 (44%) females, 152 (51%) aged ≤24 years] were included in this analysis. Eighty-one (27%) participants initiated PrEP at 1 year. Compared to baseline, there were significant reductions in the prevalence of the following self-reported HIV risk indicators at 1 year (overall, among non-PrEP initiators, and among PrEP initiators): transactional sex, ≥6 sexual partners, unprotected sex with ≥3 partners, sex while drunk, and sexually transmitted infection diagnosis/treatment. Percentage differences ranged from 10% for individuals reporting at least six sexual partners to 30% for those reporting unprotected sex with three or fewer sexual partners. There was weak evidence of association between female gender and unchanged/increased HIV risk at 1 year (adjusted OR: 1.35, 95% CI (0.84-2.17)). No other indicators, including PrEP use, were associated with unchanged/increased HIV risk at 1 year. Regular risk-reduction counselling may reduce risky sexual behaviour, while PrEP initiation may not lead to risk compensation.

Sections du résumé

BACKGROUND
HIV risk reduction counselling may reduce risk-taking behaviours. Yet, concerns remain about risk compensation among individuals initiating pre-exposure prophylaxis (PrEP).
OBJECTIVE
We assessed changes in risky sexual behaviour indicators among HIV vaccine preparedness study participants who received regular risk reduction counselling and referral for PrEP in Masaka, Uganda.
METHODS
Adults (18-39 years) at high risk of HIV infection were enrolled in the study between July 2018 and December 2021. Data were collected on socio-demographic factors (baseline) and self-reported sexual risk behaviours (baseline, six monthly). HIV testing and risk-reduction counselling and referral for PrEP were done quarterly. Participants who had completed at least 1 year of follow-up were included in the analysis. Proportional differences and McNemar chi-square tests were used to assess changes in the prevalence of self-reported risky sexual behaviour indicators between baseline and 1 year. Logistic regression was used to assess the predictors of unchanged/increased HIV risk at 1 year.
RESULTS
Three hundred participants [132 (44%) females, 152 (51%) aged ≤24 years] were included in this analysis. Eighty-one (27%) participants initiated PrEP at 1 year. Compared to baseline, there were significant reductions in the prevalence of the following self-reported HIV risk indicators at 1 year (overall, among non-PrEP initiators, and among PrEP initiators): transactional sex, ≥6 sexual partners, unprotected sex with ≥3 partners, sex while drunk, and sexually transmitted infection diagnosis/treatment. Percentage differences ranged from 10% for individuals reporting at least six sexual partners to 30% for those reporting unprotected sex with three or fewer sexual partners. There was weak evidence of association between female gender and unchanged/increased HIV risk at 1 year (adjusted OR: 1.35, 95% CI (0.84-2.17)). No other indicators, including PrEP use, were associated with unchanged/increased HIV risk at 1 year.
CONCLUSION
Regular risk-reduction counselling may reduce risky sexual behaviour, while PrEP initiation may not lead to risk compensation.

Identifiants

pubmed: 37548558
doi: 10.1080/16549716.2023.2242672
pmc: PMC10408567
doi:

Substances chimiques

AIDS Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2242672

Subventions

Organisme : Medical Research Council
ID : MC_UU_00027/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00033/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K019708/1
Pays : United Kingdom

Références

N Engl J Med. 2012 Aug 2;367(5):423-34
pubmed: 22784038
PLoS Clin Trials. 2007 May 25;2(5):e27
pubmed: 17525796
Front Microbiol. 2015 Jul 14;6:690
pubmed: 26236288
Virtual Mentor. 2014 Nov 01;16(11):909-15
pubmed: 25397651
AIDS Care. 2012;24(3):301-9
pubmed: 21933035
Medicine (Baltimore). 2021 Nov 5;100(44):e27719
pubmed: 34871265
Sex Transm Dis. 2008 Dec;35(12):1009-10
pubmed: 18936724
BMC Public Health. 2022 Mar 9;22(1):468
pubmed: 35264123
Afr J AIDS Res. 2021 Mar;20(1):6-14
pubmed: 33685378
MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4
pubmed: 16988643
PLoS One. 2017 Apr 25;12(4):e0175928
pubmed: 28441458
AIDS Care. 2002 Dec;14(6):773-8
pubmed: 12511210
BMC Infect Dis. 2014 Dec 02;14:642
pubmed: 25443542
AIDS Behav. 2015 Jul;19(7):1178-202
pubmed: 25213302
Lancet Infect Dis. 2022 Apr;22(4):447-448
pubmed: 35338865
Arch Sex Behav. 1998 Apr;27(2):155-80
pubmed: 9562899
Sex Transm Dis. 2004 Aug;31(8):469-74
pubmed: 15273579
Int J Environ Res Public Health. 2022 May 24;19(11):
pubmed: 35681962
PLoS One. 2021 May 27;16(5):e0251992
pubmed: 34043693
PLoS One. 2010 Aug 25;5(8):e12366
pubmed: 20811622
Sex Transm Dis. 2008 Dec;35(12):1002-8
pubmed: 19051397
Trop Med Int Health. 2009 Feb;14(2):196-203
pubmed: 19207177
AIDS Behav. 2016 Sep;20(9):1893-906
pubmed: 26837631
Lancet Infect Dis. 2022 Apr;22(4):541-551
pubmed: 34942091
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
Curr HIV/AIDS Rep. 2007 Dec;4(4):165-72
pubmed: 18366947
AIDS Res Ther. 2019 Aug 21;16(1):20
pubmed: 31434574
AIDS Patient Care STDS. 2020 May;34(5):228-236
pubmed: 32396478

Auteurs

Jonathan Kitonsa (J)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Sheila Kansiime (S)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Sylvia Kusemererwa (S)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Martin Onyango (M)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Berna Nayiga (B)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Anita Kabarambi (A)

Research, International Centre for Child Health and Development (ICHAD), Masaka, Uganda.

Joseph O Mugisha (JO)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Pontiano Kaleebu (P)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.

Eugene Ruzagira (E)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH